drugset / Trial / NCT03584919

Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans

NCT03584919

Completed 509 enrolled University Medical Centre Ljubljana
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A European, prospective clinical trial in which doxycycline and cefuroxime axetil were compared in the treatment of adult patients with erythema migrans included a control group to address this question. Evaluations of patients were conducted at baseline, 14 days and 2, 6, and 12 months after enrollment. Control subjects were evaluated at baseline and at 6 and 12 months. Subjective complaints that newly developed or intensified since the onset of erythema migrans or since the date of enrollment for controls were referred to as "new or increased symptoms"(NOIS).

Timeline

Start
2006-06-01
Primary completion
2007-09-30
Completion
2007-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline Small molecule 100 mg
Comparator cefuroxime axetil Small molecule 500 mg

Indications

No indication recorded.